Literature DB >> 31841592

Association Between Cigarette Smoking and Multiple Sclerosis: A Review.

Mattia Rosso1, Tanuja Chitnis1,2.   

Abstract

Importance: Cigarette smoking is a common environmental exposure and addiction, which has severe health consequences. Smoking is a risk factor for multiple sclerosis (MS); also, smoking has been associated with disease activity and overall prognosis for patients with MS. Observations: Cigarette smoking is an irritative agent on the lungs, in which a proinflammatory cascade starts that culminates in autoimmunity. Inflammation may increase the risk of MS in some individuals, in a process driven by antigen cross-reactivity between lung antigens and myelin antigens. Genetics plays a central role in the individual predisposition to mounting an autoimmune reaction. Also, free radicals, cyanates, and carbon monoxide in cigarette smoke may be directly toxic to neurons. Patients with MS who smoke have higher rates of disease activity, faster rates of brain atrophy, and a greater disability burden. Some of the outcomes of smoking were found to be reversible, which makes counseling key. Conclusions and Relevance: The pathways involved in cigarette smoking should be further analyzed to understand the mechanisms whereby smoking worsens MS prognosis. The proinflammatory and neurotoxic outcomes of cigarette smoking may be shared by other environmental exposures, such as pollution and organic solvents. From a global perspective, efforts should be made to diminish the prevalence of cigarette smoking in patients with MS.

Entities:  

Year:  2019        PMID: 31841592     DOI: 10.1001/jamaneurol.2019.4271

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  14 in total

1.  Readmission Rates in Patients With Multiple Sclerosis: A Nationwide Cohort Study.

Authors:  Akhil Padarti; Amod Amritphale; William Kilgo
Journal:  Int J MS Care       Date:  2022-05-03

Review 2.  Toxic Air Pollutants and Their Effect on Multiple Sclerosis: A Review Study.

Authors:  Mohammad Javad Mohammadi; Kourosh Zarea; Nasser Hatamzadeh; Arash Salahshouri; Asaad Sharhani
Journal:  Front Public Health       Date:  2022-07-06

3.  Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability.

Authors:  Marinos G Sotiropoulos; Hrishikesh Lokhande; Brian C Healy; Mariann Polgar-Turcsanyi; Bonnie I Glanz; Rohit Bakshi; Howard L Weiner; Tanuja Chitnis
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-05-28

4.  Conserved nicotine-activated neuroprotective pathways involve mitochondrial stress.

Authors:  J Brucker Nourse; Gilad Harshefi; Adi Marom; Abdelrahaman Karmi; Hagit Cohen Ben-Ami; Kim A Caldwell; Guy A Caldwell; Millet Treinin
Journal:  iScience       Date:  2021-02-04

5.  Little evidence for an effect of smoking on multiple sclerosis risk: A Mendelian Randomization study.

Authors:  Ruth E Mitchell; Kirsty Bates; Robyn E Wootton; Adil Harroud; J Brent Richards; George Davey Smith; Marcus R Munafò
Journal:  PLoS Biol       Date:  2020-11-30       Impact factor: 8.029

6.  Associations of Alcohol Consumption and Smoking With Disease Risk and Neurodegeneration in Individuals With Multiple Sclerosis in the United Kingdom.

Authors:  Iris Kleerekooper; Sharon Chua; Paul J Foster; S Anand Trip; Gordon T Plant; Axel Petzold; Praveen Patel
Journal:  JAMA Netw Open       Date:  2022-03-01

7.  Fine Particulate Matter Related to Multiple Sclerosis Relapse in Young Patients.

Authors:  Edouard Januel; Boris Dessimond; Augustin Colette; Isabella Annesi-Maesano; Bruno Stankoff
Journal:  Front Neurol       Date:  2021-05-21       Impact factor: 4.003

8.  Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry.

Authors:  Cecilia Smith Simonsen; Heidi Øyen Flemmen; Line Broch; Cathrine Brunborg; Pål Berg-Hansen; Stine Marit Moen; Elisabeth Gulowsen Celius
Journal:  Front Neurol       Date:  2021-06-17       Impact factor: 4.003

9.  The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progression.

Authors:  Cecilia Smith Simonsen; Heidi Øyen Flemmen; Line Broch; Cathrine Brunborg; Pål Berg-Hansen; Stine Marit Moen; Elisabeth Gulowsen Celius
Journal:  J Neurol       Date:  2020-10-22       Impact factor: 4.849

10.  Genes and environment in multiple sclerosis: Impact of temporal changes in the sex ratio on recurrence risks.

Authors:  A Dessa Sadovnick; Irene M Yee; Maria Criscuoli; Gabriele C DeLuca
Journal:  Mult Scler       Date:  2021-06-08       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.